Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

May 4, 2011

30339_dirs_2011-05-04_e0a764a4-23b9-418c-94a9-84fb7cbf5eb3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-05-04

Reporting Person: McMillan Donald A (President Pharma Systems NA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-04 Common Stock M 3000.0000 $25.5300 Acquired 16858.4646 Direct
2011-05-04 Common Stock S 3000.0000 $46.8620 Disposed 13858.4646 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-04 Stock Option (Right to Buy) $25.5300 M 3000.0000 Disposed 2015-03-09 Common Stock (3000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3712.1159 Indirect
Common Stock 1114.3029 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.